Exosome-based hybrid nanostructures for enhanced tumor targeting and hyperthermia therapy
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 205, 111915
Abstract
No abstract availableKeywords
Funding Information
- Daegu Gyeongbuk Institute of Science and Technology (21-RT-01, HI19C0642)
- Ministry of Science, ICT and Future Planning (21-RT-01, HI19C0642)
- Korea Ministry of Science and ICT (21-RT-01, HI19C0642)
- Ministry of Health and Welfare (21-RT-01, HI19C0642)
- Korea Health Industry Development Institute (21-RT-01, HI19C0642)
This publication has 35 references indexed in Scilit:
- Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticlesBiomaterials, 2013
- Doxil® — The first FDA-approved nano-drug: Lessons learnedJournal of Controlled Release, 2012
- Hybrid Nanoparticles for Detection and Treatment of CancerAdvanced Materials, 2012
- Up-Conversion Cell Imaging and pH-Induced Thermally Controlled Drug Release from NaYF4:Yb3+/Er3+@Hydrogel Core–Shell Hybrid MicrospheresACS Nano, 2012
- Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time trackingBiomaterials, 2012
- Engineering Inorganic Nanoemulsions/Nanoliposomes by Fluoride‐Silica Chemistry for Efficient Delivery/Co‐Delivery of Hydrophobic AgentsAdvanced Functional Materials, 2012
- Utilizing the folate receptor for active targeting of cancer nanotherapeuticsNano Reviews, 2012
- Adriamycin nephropathy: A model of focal segmental glomerulosclerosisNephrology, 2010
- Identification of local and circulating cancer stem cells in human liver cancerHepatology, 2008
- Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin–PEG–folate conjugateJournal of Controlled Release, 2004